McKesson Corporation (LON: 0JZU)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 60.23B |
| Revenue (ttm) | 246.35B |
| Net Income (ttm) | 1.89B |
| Shares Out | n/a |
| EPS (ttm) | 14.42 |
| PE Ratio | 31.83 |
| Forward PE | n/a |
| Dividend | 2.08 (0.35%) |
| Ex-Dividend Date | Dec 2, 2024 |
| Volume | 340 |
| Average Volume | 440 |
| Open | 586.55 |
| Previous Close | 595.71 |
| Day's Range | 578.00 - 588.25 |
| 52-Week Range | 335.28 - 588.25 |
| Beta | 0.44 |
| RSI | 51.52 |
| Earnings Date | Feb 5, 2025 |
About McKesson
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty ... [Read more]
Financial Performance
In 2023, McKesson's revenue was $308.95 billion, an increase of 11.65% compared to the previous year's $276.71 billion. Earnings were $3.00 billion, a decrease of -15.67%.
Financial numbers in USD Financial StatementsNews
BofA spotlights four bulls and two bears: LLY, TGT, PYPL, MCK, AR, and EWBC
McKesson, Vertex Pharmaceuticals among top healthcare Quant picks before Q4 earnings
Here's How Much You Would Have Made Owning McKesson Stock In The Last 15 Years
McKesson (NYSE: MCK) has outperformed the market over the past 15 years by 4.56% on an annualized basis producing an average annual return of 16.04%. Currently, McKesson has a market capitalization o...
Stan Wong's Past Picks: Mastercard, McKesson Corp. and O'Reilly Automotive
Stan Wong, portfolio manager at Scotia Wealth Management, shares his past picks; Mastercard, McKesson Corp. and O'Reilly Automotive.
McKesson Amplify Empowers State Pharmacy Associations Nationwide with Advocacy Funding
IRVING, Texas--(BUSINESS WIRE)--McKesson Amplify is intended to help protect critical pharmacy services and elevate the profession by strengthening the voice of the industry.
McKesson Corp (MCK) Completes Sale of Canadian Businesses to Birch Hill Equity Partners
McKesson Corp (MCK) Completes Sale of Canadian Businesses to Birch Hill Equity Partners
McKesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca Businesses
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) reported today that on December 30, 2024 it has closed the transaction announced in September 2024 to sell its Canada-based Rexall and ...
McKesson Corp (MCK) Announces Upcoming Financial Results Release and Conference Participation
McKesson Corp (MCK) Announces Upcoming Financial Results Release and Conference Participation
McKesson Corporation Announces Third Quarter Fiscal 2025 Earnings Release Date and Participation in January Conference
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2025 financial results after market close on Wednesday, February 5, 2025. The company will host a...
Gordon Reid's Top Picks: Booking Holdings, McKesson Corp. and Uber
Gordon Reid, president of Goodreid Investment Counsel, discusses his top picks: Booking Holdings, McKesson Corp. and Uber.
Gordon Reid's Top Picks: Broadcom, Booking Holdings, McKesson Corp. and Uber
Gordon Reid, president of Goodreid Investment Counsel, discusses his top picks: Broadcom, Booking Holdings, McKesson Corp. and Uber
Peering Into McKesson's Recent Short Interest
McKesson's (NYSE: MCK) short percent of float has fallen 9.26% since its last report. The company recently reported that it has 1.91 million shares sold short , which is 1.47% of all regular shares t...
Here's How Much $1000 Invested In McKesson 15 Years Ago Would Be Worth Today
McKesson (NYSE: MCK) has outperformed the market over the past 15 years by 3.86% on an annualized basis producing an average annual return of 15.88%. Currently, McKesson has a market capitalization o...
If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today
McKesson (NYSE: MCK) has outperformed the market over the past 20 years by 7.22% on an annualized basis producing an average annual return of 15.66%. Currently, McKesson has a market capitalization o...
Insider Sell: Leann Smith Sells 579 Shares of McKesson Corp (MCK)
Insider Sell: Leann Smith Sells 579 Shares of McKesson Corp (MCK)
12 High-Yield Dividend Aristocrats To Weather The Coming 2025 Storm In Style
The S&P is up almost 28% in 2024, and many investors worry about a melt-up followed by a sharp correction like in 2022 or 2018. A 2025 market correction is likely, but low-volatility, high-yield Divid...
Brian Madden's Past Pick: Franco Nevada, McKesson and Uber
Brian Madden, CIO of First Avenue Investment Counsel, discusses his past picks: Franco Nevada, McKesson and Uber.
McKesson Corporation (MCK) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
McKesson Corporation (NYSE:MCK) Annual Evercore ISI HealthCONx Healthcare Conference December 4, 2024 8:20 AM ETCompany ParticipantsBritt Vitalone -...
Jim Cramer looks back at the S&P 500s top performing stocks in November
'Mad Money' host Jim Cramer looks at November's top performing S&P 500 stocks and which could continue to perform into the new year.
Jim Cramer lists 10 stocks likely to perform well in December
CNBC's Jim Cramer listed ten stocks he thinks will do well in December. Cramer said winners from November usually continue to perform during the last month of the year.
Insider Decision: Steven H Collis Offloads $12.20M Worth Of Cencora Stock
Disclosed on November 26, Steven H Collis , Executive Chairman at Cencora (NYSE: COR), executed a substantial insider sell as per the latest SEC filing. What Happened: Collis opted to sell 50,000 sha...
McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network
I reiterate a 'Strong Buy' on McKesson, driven by growth from GLP-1 medications and a robust oncology network business, with a fair value of $696 per share. McKesson's acquisition of a 70% interest in...
These Analysts Boost Their Forecasts On McKesson Following Upbeat Earnings
McKesson MCK reported better-than-expected second-quarter financial results on Wednesday.
McKesson Corporation (MCK) Q2 2025 Earnings Call Transcript
McKesson Corporation (MCK) Q2 2025 Earnings Call Transcript
McKesson raises annual profit forecast on strength in its U.S. pharma segment
Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S. pharmaceuticals segment on robust demand for specialty and branded drugs.